Abstract Introduction Mitomycin C is a natural antibiotic that has been used to inhibit the proliferation of fibroblasts in scar tissue. Objective To evaluate the effectiveness and safety of topical Mitomycin C as an adjuvant in the endoscopic treatment of laryngotracheal stenoses. Data synthesis A systematic review of experimental or observational studies that have evaluated the treatment of laryngotracheal stenoses with the use of topical Mitomycin C was performed. Databases researched: LILACS, PubMed, Embase, Cochrane and Web of Science. Outcomes: resolution (symptom-free time ≥ one year), number of procedures required, and complications resulting from the procedure. A total of 15 studies (involving 387 patients) were selected. Mitomycin C was administered to every patient in 11 studies, and in 4 other studies, the patients were separated into 2 groups, 1 receiving mitomycin C, and the other not. The resolution of the stenosis evaluated in 12 studies in which the patients received mitomycin C was of 69% (95% confidence interval [95%CI]: 61-76%; I2 = 17.3%). A total of 52% of the patients (95%CI: 39-64%, 11 studies; I2 = 64.7%) were submitted to a single endoscopic procedure, and 48% (95%CI: 36-61%, 11 studies; I2 = 64.7%) were submitted to more than 1 procedure. Complications (mediastinal and subcutaneous emphysema, dysphonia, laceration or vocal fold paralysis and acute light obstruction) were reported in 9% of the patients (95%CI: 3-18%, 9 studies; I2 = 79.8%). Conclusions The evidence suggests that mitomycin C is an effective and safe option in the endoscopic treatment of laryngotracheal stenosis.

Forequarter amputations are an uncommon option for the treatment of upper limb and shoulder girdle tumors nowadays. This procedure can be done by different approaches and general anesthesia is commonly used. The authors report a case of forequarter amputation by the posterior approach performed for treatment of a soft-tissue sarcoma under a brachial plexus block associated with venous sedation and local anesthesia.

OBJETIVOS: A peritonite aguda representa uma importante causa de sepsis e óbito nas unidades de terapia intensiva e cirurgia. Classicamente o seu tratamento deve incluir: a administração sistêmica de antibióticos, a remoção mecânica dos contaminantes e a restauração da integridade gastrintestinal. A utilização de antibióticos diretamente na cavidade peritoneal é controversa. Estudo com o objetivo de avaliar o uso terapêutico, intraperitoneal da ampicilina associada ao sulbactam. MÉTODOS: foram mensurados os níveis plasmáticos do óxido nítrico, bem como a contagem de eosinófilos, linfócitos, monócitos e neutrófilos no sangue e no lavado peritoneal, utilizando-se modelo de peritonite em ratos (ligadura-transfixação cecal). Vinte quatro ratos Wistar, machos, foram divididos em quatro grupos de seis animais, assim distribuídos: grupo A: método de indução de peritonite - soltura da ligadura + tratamento com soro fisiológico; grupo B: método de indução de peritonite + soltura da ligadura + tratamento com soro fisiológico acrescido de ampicilina / sulbactam; grupo C: método de indução de peritonite + soltura da ligadura-transfixação cecal; e grupo D: laparatomia para realização de lavado peritoneal mais coleta de sangue. A ligadura-transfixação do cecum permaneceu por 24 horas, antes do tratamento instaurado. Foi realizada uma relaparotomia nos 18 ratos com coleta de líquido de lavado peritoneal e sangue. Foram dosados os níveis plasmáticos de óxido nítrico e determinado o número de eosinófilos, linfócitos, monócitos e neutrófilos no sangue e no lavado peritoneal. RESULTADOS: Não ocorreu diferença estatisticamente significante (p > 0,05) nos níveis de óxido nítrico, bem como no número de eosinófilos, linfócitos, monócitos e neutrófilos no sangue e no lavado peritoneal, entre os grupos. CONCLUSÃO: Neste estudo, concluiu-se que: a utilização de ampicilina associada a sulbactam por via intraperitoneal nos ratos com peritonite fecal: não modificou a sobrevida; não alterou os níveis plasmáticos de óxido nítrico; não alterou a contagem de eosinófilos, linfócitos, monócitos e neutrófilos tanto no sangue como no lavado peritoneal.

OBJECTIVES: The acute peritonitis is an important cause of sepsis and death on intensive care units and surgery. The treatment must include: systemical use of antibiotics, drainage of abscess and restauration of gastrointestinal integrity. The topical use of antibiotics in the peritoneal cavity is controversial. The aim of this study was to evaluate the use of topical use of ampicilin/sulbactam in the treatment of peritonitis. METHODS: We measured the plasmatic levels of nitric oxide, count of eosinophils, lymphocytes, monocytes, and neutrophils in blood and peritoneal cavity, using a model of peritonitis in rats (transfixation and ligature of cecum). Twenty four Wistar rats were divided in 4 groups (n=6 each). group A: induction of peritonitis with ligature of cecum and topical treatment with saline; group B: induction of peritonitis with ligature of cecum and topical treatment with ampicilin/sulbactam; group C: transfixation of cecum; group D: laparotomy and peritoneal exsudate + blood sample. The transfixation-ligture of cecum remained for 24 hs before treatment. A relaparotomy was performed in 18 rats and peritoneal exsudate/blood were collected. Dosage of Nitric oxide, count of eosinophil, lynphocytes, monocytes, and neutrophils in blood and peritoneal exsudte were done. RESULTS: The difference was not significant in the levels of nitric oxide, eosinophil, lynphocytes, monocytes, and neutrophils in blood and peritoneal exsudate (p > 0,05) among the studied groups. CONCLUSON: The use of ampicilin associated to sulbactam via intraperitoneal in rats with fecal peritonitis did not change survival.; the levels of plama nitric oxide, count of eosinophil, lynphocytes, monocytes, and neutrophils in blood and peritoneal exsudate were not affected.